0
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Original Article |  August 01, 2012
Interactive Effect of Apolipoprotein E Genotype and Age on Hippocampal Activation During Memory Processing in Healthy Adults
Lisa M. Nichols, PhD; Joseph C. Masdeu, MD, PhD; Venkata S. Mattay, MD; et al.
Arch Gen Psychiatry. 2012;69(8):804-813. doi:10.1001/archgenpsychiatry.2011.1893.
INCLUDES: , Supplemental Content
Original Article |  May 01, 2012 FREE
Midlife vs Late-Life Depressive Symptoms and Risk of Dementia:  Differential Effects for Alzheimer Disease and Vascular Dementia
Deborah E. Barnes, PhD, MPH; Kristine Yaffe, MD; Amy L. Byers, PhD, MPH; et al.
Arch Gen Psychiatry. 2012;69(5):493-498. doi:10.1001/archgenpsychiatry.2011.1481.
Original Article |  May 01, 2012 FREE
Effect of Purpose in Life on the Relation Between Alzheimer Disease Pathologic Changes on Cognitive Function in Advanced Age
Patricia A. Boyle, PhD; Aron S. Buchman, MD; Robert S. Wilson, PhD; et al.
Arch Gen Psychiatry. 2012;69(5):499-504. doi:10.1001/archgenpsychiatry.2011.1487.
Original Article |  January 01, 2012 FREE
Cerebrospinal Fluid Levels ofβ-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia
Peder Buchhave, MD, PhD; Lennart Minthon, MD, PhD; Henrik Zetterberg, MD, PhD; et al.
Arch Gen Psychiatry. 2012;69(1):98. doi:10.1001/archgenpsychiatry.2011.155.
INCLUDES: , Supplemental Content
Original Article |  September 01, 2011 FREE
Utility of Combinations of Biomarkers, Cognitive Markers, and Risk Factors to Predict Conversion From Mild Cognitive Impairment to Alzheimer Disease in Patients in the Alzheimer's Disease Neuroimaging Initiative
Jesus J. Gomar, PhD; Maria T. Bobes-Bascaran, MA; Concepcion Conejero-Goldberg, MD, PhD; et al.
Arch Gen Psychiatry. 2011;68(9):961-969. doi:10.1001/archgenpsychiatry.2011.96.
INCLUDES: , Supplemental Content
Original Article |  August 01, 2011 FREE
Chronic Divalproex Sodium to Attenuate Agitation and Clinical Progression of Alzheimer Disease
Pierre N. Tariot, MD; Lon S. Schneider, MD; Jeffrey Cummings, MD; et al.
Arch Gen Psychiatry. 2011;68(8):853-861. doi:10.1001/archgenpsychiatry.2011.72.
Original Article |  June 06, 2011 FREE
Functional Impairment in Elderly Patients With Mild Cognitive Impairment and Mild Alzheimer Disease
Patrick J. Brown, PhD; D. P. Devanand, MD; Xinhua Liu, PhD; et al.
Arch Gen Psychiatry. 2011;68(6):617-626. doi:10.1001/archgenpsychiatry.2011.57.
Original Article |  February 07, 2011 FREE
The Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Prediction of Neural Risk for Alzheimer Disease
Aristotle N. Voineskos, MD, PhD, FRCPC; Jason P. Lerch, PhD; Daniel Felsky, BSc; et al.
Arch Gen Psychiatry. 2011;68(2):198-206. doi:10.1001/archgenpsychiatry.2010.194.
INCLUDES: , Supplemental Content
Original Article |  February 07, 2011 FREE
The Role of Clusterin, Complement Receptor 1, and Phosphatidylinositol Binding Clathrin Assembly Protein in Alzheimer Disease Risk and Cerebrospinal Fluid Biomarker Levels
Brit-Maren M. Schjeide, BS; Cathrin Schnack, PhD; Jean-Charles Lambert, PhD; et al.
Arch Gen Psychiatry. 2011;68(2):207-213. doi:10.1001/archgenpsychiatry.2010.196.
INCLUDES: , Supplemental Content
Original Article |  July 01, 2010 FREE
Association of Plasma Clusterin Concentration With Severity, Pathology, and Progression in Alzheimer Disease
Madhav Thambisetty, MD, PhD; Andrew Simmons, PhD; Latha Velayudhan, DNB (Psychiatry); et al.
Arch Gen Psychiatry. 2010;67(7):739-748. doi:10.1001/archgenpsychiatry.2010.78.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Neurology
Original Contribution  |  June 17, 2013
Dissociable Effects of Alzheimer Disease and White Matter Hyperintensities on Brain Metabolism
Thaddeus J. Haight, PhD; Susan M. Landau, PhD; Owen Carmichael, PhD; et al.
JAMA Neurology
Original Contribution  |  April 15, 2013
C9orf72 Hexanucleotide Repeat Expansions in Clinical Alzheimer Disease
Matthew Harms, MD; Bruno A. Benitez, MD; Nigel Cairns, PhD; et al.
JAMA Neurology
Observation  |  April 22, 2013
Progranulin Mutations as Risk Factors for Alzheimer Disease
David C. Perry, MD; Manja Lehmann, PhD; Jennifer S. Yokoyama, PhD; et al.
JAMA Neurology
Viewpoint  |  April 29, 2013
DNA Aβ42 Vaccination as Possible Alternative Immunotherapy for Alzheimer Disease
Roger N. Rosenberg, MD; Doris Lambracht-Washington, PhD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems